User menu

Dynamic contrast-enhanced MRI in mouse tumors at 11.7 T: comparison of three contrast agents with different molecular weights to assess the early effects of combretastatin A4

Bibliographic reference Fruytier, Anne-Catherine ; Magat, Julie ; Neveu, Marie-Aline ; Karroum, Oussama ; Bouzin, Caroline ; et. al. Dynamic contrast-enhanced MRI in mouse tumors at 11.7 T: comparison of three contrast agents with different molecular weights to assess the early effects of combretastatin A4. In: NMR in Biomedicine, Vol. 27, no. 11, p. 1403-1412 (2014)
Permanent URL
  1. Padhani Anwar R., Miles Kenneth A., Multiparametric Imaging of Tumor Response to Therapy, 10.1148/radiol.10091760
  2. Zweifel Martin, Padhani Anwar R., Perfusion MRI in the early clinical development of antivascular drugs: decorations or decision making tools?, 10.1007/s00259-010-1451-z
  3. Jaspers Karolien, Aerts Hugo J.W.L., Leiner Tim, Oostendorp Marlies, van Riel Natal A.W., Post Mark J., Backes Walter H., Reliability of pharmacokinetic parameters: Small vs. medium-sized contrast agents, 10.1002/mrm.22035
  4. O'Connor James P. B., Jackson Alan, Parker Geoff J. M., Roberts Caleb, Jayson Gordon C., Dynamic contrast-enhanced MRI in clinical trials of antivascular therapies, 10.1038/nrclinonc.2012.2
  5. Tozer Gillian M., Kanthou Chryso, Baguley Bruce C., Disrupting tumour blood vessels, 10.1038/nrc1628
  6. TOZER GILLIAN M., KANTHOU CHRYSO, PARKINS CHARLES S., HILL SALLY A., The biology of the combretastatins as tumour vascular targeting agents : Combretastatins and tumour vascular targeting, 10.1046/j.1365-2613.2002.00211.x
  7. Zweifel M., Jayson G. C., Reed N. S., Osborne R., Hassan B., Ledermann J., Shreeves G., Poupard L., Lu S.- P., Balkissoon J., Chaplin D. J., Rustin G. J. S., Phase II trial of combretastatin A4 phosphate, carboplatin, and paclitaxel in patients with platinum-resistant ovarian cancer, 10.1093/annonc/mdq708
  8. Nathan P., Zweifel M., Padhani A. R., Koh D.-M., Ng M., Collins D. J., Harris A., Carden C., Smythe J., Fisher N., Taylor N. J., Stirling J. J., Lu S.-P., Leach M. O., Rustin G. J. S., Judson I., Phase I Trial of Combretastatin A4 Phosphate (CA4P) in Combination with Bevacizumab in Patients with Advanced Cancer, 10.1158/1078-0432.ccr-11-3376
  9. Nielsen Thomas, Murata Rumi, Maxwell Ross J., Stødkilde-Jørgensen Hans, Østergaard Leif, Ley Carsten D., Kristjansen Paul E. G., Horsman Michael R., Non-invasive imaging of combretastatin activity in two tumor models: Association with invasive estimates, 10.3109/0284186x.2010.499135
  10. Maxwell Ross J., Wilson John, Prise Vivien E., Vojnovic Borivoj, Rustin Gordon J., Lodge Martin A., Tozer Gillian M., Evaluation of the anti-vascular effects of combretastatin in rodent tumours by dynamic contrast enhanced MRI, 10.1002/nbm.754
  11. Caravan Peter, Farrar Christian T., Frullano Luca, Uppal Ritika, Influence of molecular parameters and increasing magnetic field strength on relaxivity of gadolinium- and manganese-based T1contrast agents, 10.1002/cmmi.267
  12. Fruytier, Magn. Reson. Med. (2013)
  13. Michoux Nicolas, Huwart Laurent, Abarca-Quinones Jorge, Dorvillius Mylène, Annet Laurence, Peeters Frank, Van Beers Bernard E., Transvascular and interstitial transport in rat hepatocellular carcinomas: Dynamic contrast-enhanced MRI assessment with low- and high-molecular weight agents, 10.1002/jmri.21524
  14. Leach M O, Brindle K M, Evelhoch J L, Griffiths J R, Horsman M R, Jackson A, Jayson G C, Judson I R, Knopp M V, Maxwell R J, McIntyre D, Padhani A R, Price P, Rathbone R, Rustin G J, Tofts P S, Tozer G M, Vennart W, Waterton J C, Williams S R, Workman P, The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations, 10.1038/sj.bjc.6602550
  15. de Lussanet Quido G., Langereis Sander, Beets-Tan Regina G. H., van Genderen Marcel H. P., Griffioen Arjan W., van Engelshoven Jos M. A., Backes Walter H., Dynamic Contrast-enhanced MR Imaging Kinetic Parameters and Molecular Weight of Dendritic Contrast Agents in Tumor Angiogenesis in Mice, 10.1148/radiol.2351040411
  16. Daldrup H, Shames D M, Wendland M, Okuhata Y, Link T M, Rosenau W, Lu Y, Brasch R C, Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media., 10.2214/ajr.171.4.9762973
  17. Taper, Cancer Res., 26, 143 (1966)
  18. Grosios K, Holwell S E, McGown A T, Pettit G R, Bibby M C, In vivo and in vitro evaluation of combretastatin A-4 and its sodium phosphate prodrug, 10.1038/sj.bjc.6692174
  19. Loveless Mary E., Halliday Jane, Liess Carsten, Xu Lei, Dortch Richard D., Whisenant Jennifer, Waterton John C., Gore John C., Yankeelov Thomas E., A quantitative comparison of the influence of individual versus population-derived vascular input functions on dynamic contrast enhanced-MRI in small animals, 10.1002/mrm.22988
  20. Jacquier Alexis, Bucknor Matthew, Do Loi, Robert Philippe, Corot Claire, Higgins Charles B., Saeed Maythem, P846, a new gadolinium based low diffusion magnetic resonance contrast agent, in characterizing occlusive infarcts, reperfused ischemic myocardium and reperfused infarcts in rats, 10.1007/s10334-008-0112-8
  21. Port Marc, Corot Claire, Rousseaux Olivier, Raynal Isabelle, Devoldere Ludovic, Idée Jean-Marc, Dencausse Anne, Greneur Soizic Le, Simonot C., Meyer Dominique, P792: a rapid clearance blood pool agent for magnetic resonance imaging: preliminary results, 10.1007/bf02668093
  22. GAILLARD S., KUBIAK C., STOLZ C., BONNEMAIN B., CHASSARD D., Safety and Pharmacokinetics of P792, a New Blood-Pool Agent : Results of Clinical Testing in Nonpatient Volunteers, 10.1097/00004424-200204000-00001
  23. Bourasset F., Dencausse A., Bourrinet P., Ducret M., Corot C., Comparison of plasma and peritoneal concentrations of various categories of MRI blood pool agents in a murine experimental pharmacokinetic model, 10.1007/bf02668086
  24. Lemasson Benjamin, Christen Thomas, Tizon Xavier, Farion Régine, Fondraz Nadège, Provent Peggy, Segebarth Christoph, Barbier Emmanuel L., Genne Philippe, Duchamp Olivier, Remy Chantal, Assessment of multiparametric MRI in a human glioma model to monitor cytotoxic and anti-angiogenic drug effects, 10.1002/nbm.1611
  25. Tofts Paul S., Kermode Allan G., Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts, 10.1002/mrm.1910170208
  26. Baudelet Christine, Ansiaux Réginald, Jordan Bénédicte F, Havaux Xavier, Macq Benoit, Gallez Bernard, Physiological noise in murine solid tumours using T2*-weighted gradient-echo imaging: a marker of tumour acute hypoxia?, 10.1088/0031-9155/49/15/006
  27. Sourbron Steven P., Buckley David L., Classic models for dynamic contrast-enhanced MRI : CLASSIC MODELS FOR DCE-MRI, 10.1002/nbm.2940
  28. Buckley 1David L., Parker Geoffrey J. M., Measuring Contrast Agent Concentration in T1-Weighted Dynamic Contrast-Enhanced MRI, Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Oncology ISBN:3540423222 p.69-79, 10.1007/3-540-26420-5_5
  29. Heilmann Melanie, Kiessling Fabian, Enderlin Marta, Schad Lothar R., Determination of Pharmacokinetic Parameters in DCE MRI : Consequence of Nonlinearity Between Contrast Agent Concentration and Signal Intensity, 10.1097/01.rli.0000209607.99200.53
  30. Tofts Paul S., Brix Gunnar, Buckley David L., Evelhoch Jeffrey L., Henderson Elizabeth, Knopp Michael V., Larsson Henrik B.W., Lee Ting-Yim, Mayr Nina A., Parker Geoffrey J.M., Port Ruediger E., Taylor June, Weisskoff Robert M., Estimating kinetic parameters from dynamic contrast-enhanced t1-weighted MRI of a diffusable tracer: Standardized quantities and symbols, 10.1002/(sici)1522-2586(199909)10:3<223::aid-jmri2>;2-s
  31. Dietrich Olaf, Raya José G., Reeder Scott B., Reiser Maximilian F., Schoenberg Stefan O., Measurement of signal-to-noise ratios in MR images: Influence of multichannel coils, parallel imaging, and reconstruction filters, 10.1002/jmri.20969
  32. Heilmann Melanie, Walczak Christine, Vautier Julien, Dimicoli Jean-Luc, Thomas Carole D., Lupu Mihaela, Mispelter Joël, Volk Andreas, Simultaneous dynamic T 1 and T 2 * measurement for AIF assessment combined with DCE MRI in a mouse tumor model, 10.1007/s10334-007-0082-2
  33. Weidensteiner Claudia, Rausch Martin, McSheehy Paul M.J., Allegrini Peter R., Quantitative dynamic contrast-enhanced MRI in tumor-bearing rats and mice with inversion recovery TrueFISP and two contrast agents at 4.7 T, 10.1002/jmri.20676
  34. Vautier Julien, El Tannir El Tayara Nadine, Walczak Christine, Mispelter Joël, Volk Andreas, Radial multigradient-echo DCE-MRI for 3DKtransmapping with individual arterial input function measurement in mouse tumor models : 3D Radial DCE-MRI in Mice with Individual AIF, 10.1002/mrm.24504
  35. Bradley D. P., Tessier J. L., Checkley D., Kuribayashi H., Waterton J. C., Kendrew J., Wedge S. R., Effects of AZD2171 and vandetanib (ZD6474, Zactima) on haemodynamic variables in an SW620 human colon tumour model: an investigation using dynamic contrast-enhanced MRI and the rapid clearance blood pool contrast agent, P792 (gadomelitol), 10.1002/nbm.1161
  36. de Rochefort Ludovic, Nguyen Thanh, Brown Ryan, Spincemaille Pascal, Choi Grace, Weinsaft Jonathan, Prince Martin R., Wang Yi, In vivo quantification of contrast agent concentration using the induced magnetic field for time-resolved arterial input function measurement with MRI : QSI for in vivo contrast agent concentration measurement, 10.1118/1.3002309
  37. Garpebring Anders, Wirestam Ronnie, Yu Jun, Asklund Thomas, Karlsson Mikael, Phase-based arterial input functions in humans applied to dynamic contrast-enhanced MRI: potential usefulness and limitations, 10.1007/s10334-011-0257-8
  38. O'Connor J P B, Jackson A, Parker G J M, Jayson G C, DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents, 10.1038/sj.bjc.6603515
  39. Delrue Louke J., Casneuf Veerle, Van Damme Nancy, Blanckaert Peter, Peeters Marc, Ceelen Wim P., Duyck Philippe C. O., Assessment of neovascular permeability in a pancreatic tumor model using dynamic contrast-enhanced (DCE) MRI with contrast agents of different molecular weights, 10.1007/s10334-011-0256-9
  40. Corot Claire, Port Marc, Raynal Isabelle, Dencausse Anne, Schaefer Michel, Rousseaux Olivier, Simonot Christian, Devoldere Ludovic, Lin Jin, Foulon Marc, Bourrinet Philippe, Bonnemain Bruno, Meyer Dominique, Physical, chemical, and biological evaluations of P760: A new gadolinium complex characterized by a low rate of interstitial diffusion, 10.1002/(sici)1522-2586(200002)11:2<182::aid-jmri16>;2-5
  41. Cheng Hai-Ling Margaret, Wallis Chad, Shou Zhiping, Farhat Walid A., Quantifying angiogenesis in VEGF-enhanced tissue-engineered bladder constructs by dynamic contrast-enhanced MRI using contrast agents of different molecular weights, 10.1002/jmri.20787
  42. Feng Yi, Jeong Eun-Kee, Mohs Aaron M., Emerson Lyska, Lu Zheng-Rong, Characterization of tumor angiogenesis with dynamic contrast-enhanced MRI and biodegradable macromolecular contrast agents in mice, 10.1002/mrm.21791
  43. Cron Greg O., Beghein Nelson, Ansiaux Réginald, Martinive Philippe, Feron Olivier, Gallez Bernard, 19F NMR in vivo spectroscopy reflects the effectiveness of perfusion-enhancing vascular modifiers for improving gemcitabine chemotherapy, 10.1002/mrm.21469
  44. Turetschek Karl, Floyd Eugenia, Shames David M., Roberts Timothy P.L., Preda Anda, Novikov Viktor, Corot Claire, Carter Wayne O., Brasch Robert C., Assessment of a rapid clearance blood pool MR contrast medium (P792) for assays of microvascular characteristics in experimental breast tumors with correlations to histopathology, 10.1002/mrm.1117
  45. Kuwatsuru Ryohei, Shames David M., Mühler Andreas, Mintorovitch Jan, Vexler Vladimir, Mann Jeffry S., Cohn Frederic, Price David, Huberty John, Brasch Robert C., Quantification of tissue plasma volume in the rat by contrast-enhanced magnetic resonance imaging, 10.1002/mrm.1910300112
  46. Sourbron Steven P., Buckley David L., On the scope and interpretation of the Tofts models for DCE-MRI, 10.1002/mrm.22861
  47. Luypaert Robert, Sourbron Steven, de Mey Johan, Validity of perfusion parameters obtained using the modified Tofts model: A simulation study : Validity of the Modified Tofts Model, 10.1002/mrm.22728
  48. Tozer, Cancer Res., 59, 1626 (1999)
  49. Zhao D., Richer E., Antich P. P., Mason R. P., Antivascular effects of combretastatin A4 phosphate in breast cancer xenograft assessed using dynamic bioluminescence imaging and confirmed by MRI, 10.1096/fj.07-103713
  50. Galbraith Susan M., Maxwell Ross J., Lodge Martin A., Tozer Gillian M., Wilson John, Taylor N. Jane, Stirling J. James, Sena Luiza, Padhani Anwar R., Rustin Gordon J.S., Combretastatin A4 Phosphate Has Tumor Antivascular Activity in Rat and Man as Demonstrated by Dynamic Magnetic Resonance Imaging, 10.1200/jco.2003.05.187
  51. Ewing James R., Bagher-Ebadian Hassan, Model selection in measures of vascular parameters using dynamic contrast-enhanced MRI: experimental and clinical applications : MODEL SELECTION IN DYNAMIC CONTRAST-ENHANCED MRI, 10.1002/nbm.2996
  52. McGrath Deirdre M., Bradley Daniel P., Tessier Jean L., Lacey Tony, Taylor Chris J., Parker Geoffrey J.M., Comparison of model-based arterial input functions for dynamic contrast-enhanced MRI in tumor bearing rats, 10.1002/mrm.21959
  53. Larsson Henrik B. W., Courivaud Frédéric, Rostrup Egill, Hansen Adam E., Measurement of brain perfusion, blood volume, and blood-brain barrier permeability, using dynamic contrast-enhancedT1-weighted MRI at 3 tesla, 10.1002/mrm.22136
  54. Jaspers Karolien, Leiner Tim, Dijkstra Petra, Oostendorp Marlies, van Golde Jolanda M., Post Mark J., Backes Walter H., Optimized pharmacokinetic modeling for the detection of perfusion differences in skeletal muscle with DCE-MRI: Effect of contrast agent size : Contrast agent size in DCE-MRI of muscle perfusion, 10.1118/1.3484057
  55. Li Xin, Huang Wei, Yankeelov Thomas E., Tudorica Alina, Rooney William D., Springer Charles S., Shutter-speed analysis of contrast reagent bolus-tracking data: Preliminary observations in benign and malignant breast disease, 10.1002/mrm.20405